• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病合并糖尿病肾病及慢性肾脏病患者的管理策略

Management Strategies for Patients with Diabetic Kidney Disease and Chronic Kidney Disease in Diabetes.

作者信息

Yakush Williams Jessica K

机构信息

Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

出版信息

Nurs Clin North Am. 2017 Dec;52(4):575-587. doi: 10.1016/j.cnur.2017.07.007. Epub 2017 Oct 5.

DOI:10.1016/j.cnur.2017.07.007
PMID:29080579
Abstract

Diabetes mellitus is a leading cause of chronic kidney disease, prompting the need for monitoring and management of this complex condition in those diagnosed with diabetes. Management is often multifaceted and includes lifestyle modification, management of hyperglycemia, and management of hypertension and hyperlipidemia to slow progression of kidney disease and to mitigate cardiovascular risks associated with diabetes and kidney disease. This article reviews the current literature regarding monitoring and management of diabetic kidney disease and chronic kidney disease in diabetes.

摘要

糖尿病是慢性肾脏病的主要病因,这促使对糖尿病患者的这一复杂病症进行监测和管理。管理通常是多方面的,包括生活方式改变、高血糖管理、高血压和高脂血症管理,以减缓肾脏疾病进展并降低与糖尿病和肾脏疾病相关的心血管风险。本文综述了有关糖尿病肾病和糖尿病合并慢性肾脏病监测与管理的当前文献。

相似文献

1
Management Strategies for Patients with Diabetic Kidney Disease and Chronic Kidney Disease in Diabetes.糖尿病合并糖尿病肾病及慢性肾脏病患者的管理策略
Nurs Clin North Am. 2017 Dec;52(4):575-587. doi: 10.1016/j.cnur.2017.07.007. Epub 2017 Oct 5.
2
Management of the diabetic patient with advanced chronic kidney disease.晚期慢性肾病糖尿病患者的管理
Semin Dial. 2010 Mar-Apr;23(2):140-7. doi: 10.1111/j.1525-139X.2010.00700.x. Epub 2010 Mar 30.
3
Practical management of diet and lifestyle interventions for people with diabetes or cardiovascular disease.糖尿病或心血管疾病患者饮食与生活方式干预的实际管理
J Ren Care. 2010 May;36 Suppl 1:76-85. doi: 10.1111/j.1755-6686.2010.00175.x.
4
Diabetic kidney disease: a report from an ADA Consensus Conference.糖尿病肾病:ADA 共识会议报告。
Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001.
5
The diabetic CKD patient--a major cardiovascular challenge.糖尿病慢性肾脏病患者——心血管领域的重大挑战。
J Ren Care. 2010 May;36 Suppl 1:34-46. doi: 10.1111/j.1755-6686.2010.00165.x.
6
Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.年龄、肾功能障碍、心血管疾病和 2 型糖尿病的抗高血糖治疗:来自意大利肾功能不全和心血管事件多中心研究的发现。
J Am Geriatr Soc. 2013 Aug;61(8):1253-61. doi: 10.1111/jgs.12381. Epub 2013 Jul 26.
7
Rationale and strategies for early detection and management of diabetic kidney disease.糖尿病肾病早期检测与管理的基本原理和策略
Mayo Clin Proc. 2008 Dec;83(12):1373-81. doi: 10.1016/S0025-6196(11)60786-6.
8
Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?使用肾素-血管紧张素系统抑制剂进行降压治疗能否预防糖尿病肾病的发生?
BMC Pharmacol Toxicol. 2015 Sep 11;16:22. doi: 10.1186/s40360-015-0024-y.
9
The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.2009年世界肾脏日的主题:高血压与肾脏疾病——一段应被阻止的“联姻”。
J Hypertens. 2009 Mar;27(3):666-9. doi: 10.1097/HJH.0b013e328327706a.
10
Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.血管紧张素转换酶抑制剂和血管紧张素Ⅱ受体拮抗剂应用20年后:糖尿病肾病的新兴治疗策略
Am J Physiol Renal Physiol. 2015 Nov 15;309(10):F807-20. doi: 10.1152/ajprenal.00266.2015. Epub 2015 Sep 2.

引用本文的文献

1
Ageing, clinical complexity, and exercise therapy: a multidimensional approach.衰老、临床复杂性与运动疗法:一种多维度方法
Front Sports Act Living. 2025 Jan 6;6:1422222. doi: 10.3389/fspor.2024.1422222. eCollection 2024.
2
Diabetes mellitus is a risk factor for incident chronic kidney disease: A nationwide cohort study.糖尿病是新发慢性肾脏病的一个危险因素:一项全国性队列研究。
Heliyon. 2024 Mar 27;10(7):e28780. doi: 10.1016/j.heliyon.2024.e28780. eCollection 2024 Apr 15.
3
Mitogen-activating protein kinase kinase kinase kinase-3, inhibited by Astragaloside IV through H3 lysine 4 monomethylation, promotes the progression of diabetic nephropathy by inducing apoptosis.
丝裂原活化蛋白激酶激酶激酶激酶-3通过H3赖氨酸4单甲基化被黄芪甲苷抑制,其通过诱导细胞凋亡促进糖尿病肾病进展。
Bioengineered. 2022 May;13(5):11517-11529. doi: 10.1080/21655979.2022.2068822.
4
Magic and mystery of microRNA-32.miRNA-32 的神奇与奥秘。
J Cell Mol Med. 2021 Sep;25(18):8588-8601. doi: 10.1111/jcmm.16861. Epub 2021 Aug 18.
5
for Diabetic Nephropathy: A Systematic Review and Meta-Analysis.糖尿病肾病:一项系统评价与荟萃分析
Evid Based Complement Alternat Med. 2019 Apr 18;2019:9679234. doi: 10.1155/2019/9679234. eCollection 2019.
6
Codonopsis tangshen Oliv. Amelioration Effect on Diabetic Kidney Disease Rats Induced by High Fat Diet Feeding Combined with Streptozotocin.党参对高脂饮食联合链脲佐菌素诱导的糖尿病肾病大鼠的改善作用
Nat Prod Bioprospect. 2018 Dec;8(6):441-451. doi: 10.1007/s13659-018-0187-5. Epub 2018 Nov 1.
7
Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy.3-MA 通过抑制自噬对高尿酸血症肾病具有保护作用。
Clin Sci (Lond). 2018 Nov 2;132(21):2299-2322. doi: 10.1042/CS20180563. Print 2018 Nov 15.
8
Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats.黄芪甲苷IV/长链非编码RNA-TUG1/肿瘤坏死因子受体相关因子5信号通路参与糖尿病肾病大鼠足细胞凋亡
Drug Des Devel Ther. 2018 Sep 6;12:2785-2793. doi: 10.2147/DDDT.S166525. eCollection 2018.